ICON Public Limited Company

ICLR ·Healthcare, Diagnostics & Research, Ireland
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $1.76B $1.67B $1.57B $1.50B $1.34B $1.12B $945.7M $900.0M
Cost of Revenue $1.03B $961.3M $909.0M $903.2M $845.4M $717.8M $611.9M $541.4M
Gross Profit $731.1M $705.2M $666.0M $600.1M $490.6M $397.3M $333.8M $358.7M
Gross Margin 41.6% 42.3% 42.3% 39.9% 36.7% 35.6% 35.3% 39.8%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $323.7M $325.7M $326.8M $336.5M $313.9M $280.8M $255.9M $232.7M
Operating Income $338.3M $311.7M $281.5M $202.4M $121.2M $68.0M $29.4M $92.1M
Operating Margin 19.2% 18.7% 17.9% 13.5% 9.1% 6.1% 3.1% 10.2%
Interest Expense $12.6M $13.0M $4.0M $785.0K $1.3M $1.9M $1.6M $1.1M
Pretax Income $328.1M $300.2M $278.9M $202.7M $120.9M $67.2M $29.0M $92.7M
Income Tax Expense $46.6M $38.0M $39.3M $30.2M $18.1M $11.8M $6.1M $5.7M
Net Income $281.5M $262.2M $239.5M $172.5M $102.8M $55.4M $22.9M $87.1M
Net Margin 16.0% 15.7% 15.2% 11.5% 7.7% 5.0% 2.4% 9.7%
EPS (Basic) $5.20 $4.75 $4.08 $2.80 $1.69 $0.92 $0.38 $1.46
EPS (Diluted) $5.13 $4.65 $3.97 $2.73 $1.65 $0.92 $0.37 $1.44
Shares Outstanding (Basic) 54.1M 55.2M 58.7M 61.5M 60.9M 60.0M 60.4M 59.7M
Shares Outstanding (Diluted) 54.8M 56.4M 60.3M 63.1M 62.3M 60.5M 61.1M 60.6M
Dividends Per Share — — — — — — — —
← Newer Page 2 of 3 Older →